HER2 expression in circulating tumour cells isolated from metastatic breast cancer patients using a size-based microfluidic device
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10451/49548 |
Resumo: | © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
id |
RCAP_3af0379e80a0d0552ef44d03b1810458 |
---|---|
oai_identifier_str |
oai:repositorio.ul.pt:10451/49548 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
HER2 expression in circulating tumour cells isolated from metastatic breast cancer patients using a size-based microfluidic deviceHER2Breast cancerCirculating tumour cellsLiquid biopsyMicrofluidicsOverall survival© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).HER2 is a prognostic and predictive biomarker in breast cancer, normally assessed in tumour biopsy and used to guide treatment choices. Circulating tumour cells (CTCs) escape the primary tumour and enter the bloodstream, exhibiting great metastatic potential and representing a real-time snapshot of the tumour burden. Liquid biopsy offers the unique opportunity for low invasive sampling in cancer patients and holds the potential to provide valuable information for the clinical management of cancer patients. This study assesses the performance of the RUBYchip™, a microfluidic system for CTC capture based on cell size and deformability, and compares it with the only FDA-approved technology for CTC enumeration, CellSearch®. After optimising device performance, 30 whole blood samples from metastatic breast cancer patients were processed with both technologies. The expression of HER2 was assessed in isolated CTCs and compared to tissue biopsy. Results show that the RUBYchipTM was able to isolate CTCs with higher efficiency than CellSearch®, up to 10 times more, averaging all samples. An accurate evaluation of different CTC subpopulations, including HER2+ CTCs, was provided. Liquid biopsy through the use of the RUBYchipTM in the clinic can overcome the limitations of histological testing and evaluate HER2 status in patients in real-time, helping to tailor treatment during disease evolution.This work was supported by the CANCER project (NORTE-01-0145-FEDER-000029) co-funded through the NORTE-45-2015-02 program, the RESOLVE project (NORTE-01-0246-FEDER-000018) funded through the Norte2020, and the Safe-N-Medtech project (H2020-NMBP-02-2018) funded through Horizon 2020. The project leading to these results has also received funding and support from the “la Caixa” Foundation under CaixaImpulse Grant LCF/TR/CC20/52480003 (CTC-OD).MDPIRepositório da Universidade de LisboaLopes, CláudiaPiairo, PaulinaChícharo, AlexandreAbalde-Cela, SaraPires, Liliana R.Corredeira, PatríciaAlves, PatríciaMuinelo-Romay, LauraCosta, LuisDiéguez, Lorena2021-09-20T14:54:43Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/49548engCancers (Basel). 2021 Sep 3;13(17):444610.3390/cancers131744462072-6694info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-11-20T18:09:04Zoai:repositorio.ul.pt:10451/49548Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-11-20T18:09:04Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
HER2 expression in circulating tumour cells isolated from metastatic breast cancer patients using a size-based microfluidic device |
title |
HER2 expression in circulating tumour cells isolated from metastatic breast cancer patients using a size-based microfluidic device |
spellingShingle |
HER2 expression in circulating tumour cells isolated from metastatic breast cancer patients using a size-based microfluidic device Lopes, Cláudia HER2 Breast cancer Circulating tumour cells Liquid biopsy Microfluidics Overall survival |
title_short |
HER2 expression in circulating tumour cells isolated from metastatic breast cancer patients using a size-based microfluidic device |
title_full |
HER2 expression in circulating tumour cells isolated from metastatic breast cancer patients using a size-based microfluidic device |
title_fullStr |
HER2 expression in circulating tumour cells isolated from metastatic breast cancer patients using a size-based microfluidic device |
title_full_unstemmed |
HER2 expression in circulating tumour cells isolated from metastatic breast cancer patients using a size-based microfluidic device |
title_sort |
HER2 expression in circulating tumour cells isolated from metastatic breast cancer patients using a size-based microfluidic device |
author |
Lopes, Cláudia |
author_facet |
Lopes, Cláudia Piairo, Paulina Chícharo, Alexandre Abalde-Cela, Sara Pires, Liliana R. Corredeira, Patrícia Alves, Patrícia Muinelo-Romay, Laura Costa, Luis Diéguez, Lorena |
author_role |
author |
author2 |
Piairo, Paulina Chícharo, Alexandre Abalde-Cela, Sara Pires, Liliana R. Corredeira, Patrícia Alves, Patrícia Muinelo-Romay, Laura Costa, Luis Diéguez, Lorena |
author2_role |
author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório da Universidade de Lisboa |
dc.contributor.author.fl_str_mv |
Lopes, Cláudia Piairo, Paulina Chícharo, Alexandre Abalde-Cela, Sara Pires, Liliana R. Corredeira, Patrícia Alves, Patrícia Muinelo-Romay, Laura Costa, Luis Diéguez, Lorena |
dc.subject.por.fl_str_mv |
HER2 Breast cancer Circulating tumour cells Liquid biopsy Microfluidics Overall survival |
topic |
HER2 Breast cancer Circulating tumour cells Liquid biopsy Microfluidics Overall survival |
description |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-09-20T14:54:43Z 2021 2021-01-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10451/49548 |
url |
http://hdl.handle.net/10451/49548 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Cancers (Basel). 2021 Sep 3;13(17):4446 10.3390/cancers13174446 2072-6694 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
MDPI |
publisher.none.fl_str_mv |
MDPI |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
mluisa.alvim@gmail.com |
_version_ |
1817549154072657920 |